H.R.3689 - Ovarian Cancer Biomarker Research Act of 2007

To amend the Public Health Service Act to authorize the Director of the National Cancer Institute to make grants for the discovery and validation of biomarkers for use in risk stratification for, and the early detection and screening of, ovarian cancer. view all titles (2)

All Bill Titles

  • Official: To amend the Public Health Service Act to authorize the Director of the National Cancer Institute to make grants for the discovery and validation of biomarkers for use in risk stratification for, and the early detection and screening of, ovarian cancer. as introduced.
  • Short: Ovarian Cancer Biomarker Research Act of 2007 as introduced.

This Bill currently has no wiki content. If you would like to create a wiki entry for this bill, please Login, and then select the wiki tab to create it.

Bill’s Views

  • Today: 1
  • Past Seven Days: 1
  • All-Time: 1,255
 
Introduced
 
House
Passes
 
Senate
Passes
 
President
Signs
 

 
09/27/07
 
 
 
 
 
 
 

Official Summary

Ovarian Cancer Biomarker Research Act of 2007 - Amends the Public Health Service Act to require the Director of the National Cancer Institute to enter into cooperative agreements with, or make grants to, public or nonprofit entities to establish and operate centers to conduct research on bi

Official Summary

Ovarian Cancer Biomarker Research Act of 2007 - Amends the Public Health Service Act to require the Director of the National Cancer Institute to enter into cooperative agreements with, or make grants to, public or nonprofit entities to establish and operate centers to conduct research on biomarkers for use in risk stratification for, and the early detection and screening of, ovarian cancer. Designates each center as an Ovarian Cancer Biomarker Center of Excellence.Allows federal payments under such an agreement or grant to be used for research on:
(1) the development and characterization of new biomarkers and the refinement of existing biomarkers;
(2) the clinical and laboratory validation of such biomarkers;
(3) the development and implementation of clinical and epidemiological research on the utilization of such biomarkers; and
(4) the development and implementation of repositories for new tissue, urine, serum, and other biological specimens.Requires the Director to:
(1) make available for research banked serum and tissue specimens from clinical research regarding ovarian cancer that was funded by the Department of Health and Human Services (HHS);
(2) establish an Ovarian Cancer Biomarker Clinical Trial Committee to assist the Director to design and implement national clinical trials to determine the utility of such biomarkers; and
(3) establish a national data center to conduct statistical analyses of trial data.

...Read the Rest




Vote on This Bill

-% Users Support Bill

0 in favor / 0 opposed
 

Send Your Rep a Letter

about this bill Support Oppose Tracking
Track with MyOC